Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability

por Widmer, N, Decosterd, L A, Leyvraz, S, Duchosal, M A, Rosselet, A, Debiec-Rychter, M, Csajka, C, Biollaz, J, Buclin, T
Publicado 2008